MANE insider transaction filings
Veradermics, Inc — 20 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-03. Screen MANE transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 5 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 15 legs across 4 filings by 7 insiders — 961,000 shares, $103,119,917 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 690,601 shares @ $107.25 ($74,066,957) by MONTANOVA CAPITAL, LLC, filed 2026-08-21.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC — Director & Cowen Aaron & Averill Master Fund, Ltd. — Director & Averill Madison Master Fund, Ltd. — Director | 1 | — | 2 legs · 750,000 sh · $80,437,500 | 4 |
| CHILDS JOHN W — Director | 1 | — | 3 legs · 100,000 sh · $10,711,700 | — |
| Waldman Reid Alexander — Chief Executive Officer, Director | 1 | — | 5 legs · 67,500 sh · $7,280,713 | 2 |
| Durso Timothy August — Chief Technical Officer | 1 | — | 5 legs · 43,500 sh · $4,690,005 | 2 |
| Hollander David — Chief R&D Officer | 1 | — | — | 2 |
Recent Form 4 filings — Veradermics, Inc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Hollander David — Chief R&D Officer | Grant/award (A): 9,650 @ $0 · Grant/award (A): 19,300 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | MONTANOVA CAPITAL, LLC — Director Cowen Aaron Averill Master Fund, Ltd. — Director Averill Madison Master Fund, Ltd. — Director | Sale (S): 690,601 @ $107.25 · Sale (S): 59,399 @ $107.25 · Option exercise/expiry (X): 149,000 · Option exercise/expiry (X): 151,000 · Option exercise/expiry (X): 149,000 (derivative) @ $0 · Option exercise/expiry (X): 151,000 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Durso Timothy August — Chief Technical Officer | Option exercise (M): 3,452 @ $12.19 · Sale (S): 7,918 @ $106.71 · Sale (S): 16,306 @ $107.52 · Sale (S): 16,767 @ $108.38 · Sale (S): 2,348 @ $109.34 · Sale (S): 161 @ $111.28 · +1 more | EDGAR |
| 2026-08-18 | 4 | Waldman Reid Alexander — Chief Executive Officer, Director | Option exercise (M): 3,452 @ $12.19 · Sale (S): 11,527 @ $106.72 · Sale (S): 25,234 @ $107.53 · Sale (S): 27,490 @ $108.45 · Sale (S): 3,000 @ $109.38 · Sale (S): 249 @ $111.28 · +1 more | EDGAR |
| 2026-08-14 | 4 | CHILDS JOHN W — Director | Sale (S): 15,000 @ $106.14 · Sale (S): 80,000 @ $107.23 · Sale (S): 5,000 @ $108.24 | EDGAR |
| 2026-05-05 | 4 | SUVRETTA CAPITAL MANAGEMENT, LLC — Director Cowen Aaron Averill Master Fund, Ltd. — Director Averill Madison Master Fund, Ltd. — Director | Grant/award (A): 149,000 (derivative) @ $100.00 · Grant/award (A): 151,000 (derivative) @ $100.00 | EDGAR |
| 2026-02-27 | 4/A | CHILDS JOHN W — Director | Purchase (P): 294,117 @ $17 | EDGAR |
| 2026-02-09 | 4 | SUVRETTA CAPITAL MANAGEMENT, LLC — Director, 10% owner Cowen Aaron — 10% owner Averill Master Fund, Ltd. — Director, 10% owner Averill Madison Master Fund, Ltd. — Director, 10% owner | Purchase (P): 10,004 @ $34.25 · Purchase (P): 10,676 @ $34.74 · Purchase (P): 14,659 @ $36.27 · Purchase (P): 53,344 @ $37.11 · Purchase (P): 25,908 @ $38.09 · Purchase (P): 18,489 @ $38.90 · +13 more | EDGAR |
| 2026-02-05 | 4 | Grant-Kels Jane M. — Director | Conversion (C): 2,455 · Conversion (C): 2,455 (derivative) · Grant/award (A): 51,525 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Friedman David Matthew — Director | Grant/award (A): 43,000 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Longitude Capital Partners V, LLC — 10% owner Longitude 103.8 East Partners, LLC — 10% owner Longitude 103.8 East, L.P. — 10% owner Longitude Venture Partners V, L.P. — 10% owner | Conversion (C): 1,236,631 · Conversion (C): 1,171,121 · Conversion (C): 1,171,121 · Purchase (P): 192,647 @ $17 · Purchase (P): 882,353 @ $17 · Conversion (C): 1,236,631 (derivative) · +2 more | EDGAR |
| 2026-02-05 | 4 | Carrano Dominic Gabriel — Chief Financial Officer | Grant/award (A): 148,011 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Durso Timothy August — Chief Technical Officer | Conversion (C): 1,473 · Conversion (C): 1,473 (derivative) · Grant/award (A): 213,352 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Waldman Reid Alexander — Chief Executive Officer, Director | Conversion (C): 1,437 · Conversion (C): 1,437 (derivative) · Grant/award (A): 556,399 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Pance Katarina — Director | Grant/award (A): 43,000 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Greco Michael V. — General Counsel | Grant/award (A): 144,401 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Neumann Mark — Chief Commercial Officer | Grant/award (A): 102,885 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Coric Vlad — Director | Conversion (C): 33,706 · Conversion (C): 33,706 · Conversion (C): 148,794 · Conversion (C): 148,794 · Conversion (C): 78,075 · Conversion (C): 78,075 · +11 more | EDGAR |
| 2026-02-05 | 4 | ENRIGHT PATRICK G — Director, 10% owner | Conversion (C): 1,236,631 · Conversion (C): 1,171,121 · Conversion (C): 1,171,121 · Purchase (P): 192,647 @ $17 · Purchase (P): 882,353 @ $17 · Conversion (C): 1,236,631 (derivative) · +3 more | EDGAR |
| 2026-02-05 | 4 | CHILDS JOHN W — Director | Conversion (C): 480,269 · Conversion (C): 906,862 · Conversion (C): 520,758 · Purchase (P): 294,117 @ $17 · Conversion (C): 480,269 (derivative) · Conversion (C): 906,862 (derivative) · +2 more | EDGAR |
Recent 8-K events — Veradermics, Inc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-15 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-27 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-27 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2026-03-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-05 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MANE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →